History | Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 119 KB)

Published:

26 July 2017

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 448 KB)

Published:

02 June 2017
Committee papers (PDF 3.21 MB)

Published:

02 June 2017
Public committee slides (PDF 915 KB)

Published:

02 June 2017

Draft guidance

Draft guidance
Appraisal consultation document (PDF 432 KB)

Published:

14 March 2017
Committee papers (PDF 27.9 MB)

Published:

14 March 2017
Public committee slides (PDF 619 KB)

Published:

14 March 2017

Invitation to participate

Equality Impact Assessment (Guidance development) (PDF 119 KB)

Published:

14 September 2016
Final scope (PDF 105 KB)

Published:

14 September 2016
Final matrix (PDF 97 KB)

Published:

14 September 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 191 KB)

Published:

14 September 2016